Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Antigenics buoyed by brain-cancer study
Bizjournals.com
Monday, October 26, 2009 - 11:36am
tags:
brain cancer, Antigenics
Cephalon close to buying BioAssets, developer of sciatica treatment
Bizjournals.com
Monday, October 26, 2009 - 11:32am
tags:
sciatica, Cephalon, M&A, BioAssets
SuperGen, GlaxoSmithKline sign collaboration deal
Marketwatch
Monday, October 26, 2009 - 9:43am
tags:
GSK, Supergen, partnerships, drug development
For AstraZeneca, Making Drugs Is Like Making Cars
Pharmalot
Monday, October 26, 2009 - 9:41am
tags:
AstraZeneca
Brain Disease Found in 3rd Patient on Roche’s Rituxan
Bloomberg
Monday, October 26, 2009 - 9:40am
tags:
Roche, Genentech, arthritis, Rituxan
Ranbaxy Posts Profit on Lower Costs, Currencies
Bloomberg
Monday, October 26, 2009 - 9:30am
tags:
Ranbaxy, India, earnings
Swine Flu Doesn't Need to Save Novartis
Motley Fool
Monday, October 26, 2009 - 9:29am
tags:
Novartis, swine flu, H1N1, vaccines
FDA Approves Use of Experimental Antiviral For H1N1 Flu
WSJ Online
Monday, October 26, 2009 - 9:26am
tags:
antivirals, Biocryst, swine flu, H1N1, FDA
J&J wants deals with rivals to share risk
FT.com
Monday, October 26, 2009 - 9:24am
tags:
JNJ, M&A
Venture Capital Flows to Biotech as Public Financing Takes a Breather
Seeking Alpha
Sunday, October 25, 2009 - 12:40pm
tags:
biotech
Divi’s Laboratories: Buy
istockanalyst.com
Sunday, October 25, 2009 - 12:34pm
tags:
Divi's Laboratories
AEterna Zentaris Receives US$5.5 Million from Institutional Investors
Yahoo/PR NewsWire
Saturday, October 24, 2009 - 11:15am
tags:
Aeterna Zentaris
Eli Lilly Settles Zyprexa Suit with South Carolina
New York Times
Saturday, October 24, 2009 - 11:14am
tags:
Zyprexa, Eli Lilly
Emergency Use Authorization Granted For BioCryst's Peramivir
Reuters
Saturday, October 24, 2009 - 11:10am
tags:
Biocryst, peramivir
Pfizer slaps Unilab with patent suit over contested drug
Inquirer.net
Saturday, October 24, 2009 - 11:08am
tags:
Pfizer, Unilab, Lipitor
Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer
Reuters
Saturday, October 24, 2009 - 11:06am
tags:
Exelixis, Bristol-Myers Squibb
Allergan Announces Victory in Brimonidine Patent Infringement Case
Yahoo/Zacks
Saturday, October 24, 2009 - 11:02am
tags:
Allergan
Alexion Beats, Raises Outlook
Yahoo/Zacks
Saturday, October 24, 2009 - 11:01am
tags:
Alexion
CEPH's Nuvigil Faces Generic Threat
Yahoo/Zacks
Saturday, October 24, 2009 - 10:53am
tags:
NUVIGIL, Cephalon, Provigil
Medicines Co. gets positive EU panel result
Yahoo/AP
Saturday, October 24, 2009 - 10:52am
tags:
Medicines Company, Angiox

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.